• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


Shlomo Vinker, MD

Latest:

Changing Electronic Formats Is Associated With Changes in Number of Laboratory Tests Ordered

A slight decrease in the convenience of ordering a laboratory test led to a dramatic decrease in test utilization.




Yasuhiro Kishi, MD, PhD

Latest:

General Medical Claims for Behavioral Health Patients in Japan

This Japanese cohort shows that behavioral health service users had health care costs higher than those of individuals who did not use behavioral health services, yet lower than the costs demonstrated by studies in US populations.



Matthew McKillop, MD

Latest:

Electronic Consults for Improving Specialty Care Access for Veterans

The combination of electronic consultations and active triage of specialty care consults effectively reduces wait times for outpatient clinics.




Patricia K. Corey-Lisle, PhD

Latest:

Absenteeism and Productivity Among Employees Being Treated for Hepatitis C

Employees with hepatitis C (HCV) who underwent existing treatments had more absences and higher indirect costs than HCVinfected employees who did not undergo treatment.


Jean Baltz, MMSc, MSW

Latest:

Relationship of Diabetes Complications Severity to Healthcare Utilization and Costs Among Medicare Advantage Beneficiaries

This retrospective cohort study in a Medicare Advantage population posits that type 2 diabetes mellitus complications pose an excess burden on healthcare resource use and related costs.



Shiming Dong, MS

Latest:

Using Administrative Claims to Identify Children With Chronic Conditions in a Statewide Immunization Registry

This study examines the feasibility and utility of using administrative claims from commercial health plans to identify children with chronic conditions in a statewide registry.




Carter Coberley, PhD

Latest:

Impact of a Scalable Care Transitions Program for Readmission Avoidance

The 30-day readmission risk was reduced 25% by a collaborative program model employing discharge planning and telephonic follow-up for high-risk patients with CMS penalty diagnoses.


Robin E. Clark, PhD

Latest:

Behavioral Health Disorders and Adherence to Measures of Diabetes Care Quality

Persons with substance use disorders were less likely and persons with schizophrenia/paranoia were more likely to be adherent to measures of diabetes care quality.





Lori Uscher-Pines, PhD

Latest:

Health of Medicare Advantage Plan Enrollees at 1 Year After Hurricane Katrina

At 1 year after Hurricane Katrina, the health burden of enrollees increased significantly more versus a comparison group. Emergency department visits and hospitalizations remained elevated.


Daniel M. Blumenthal, MD, MBA

Latest:

Value of Improved Lipid Control in Patients at High Risk for Adverse Cardiac Events

Reducing lipid levels in high-risk patients can significantly reduce disease burden and, depending on final negotiated prices, PCSK9 inhibitors can make an economic contribution to this goal.



Swapnil Rajpathak, MD

Latest:

Cost-Effectiveness of DPP-4 Inhibitor and SGLT2 Inhibitor Combination Therapy for Type 2 Diabetes

This study evaluates the long-term cost-effectiveness of treatment involving combination therapy with dipeptidyl peptidase 4 (DPP-4) inhibitors and sodium-glucose cotransporter 2 (SGLT2) inhibitors compared with an alternative with sulfonyureas prior to insulin initiation on a background of metformin.


Ruth Pe Benito, MPH, BS

Latest:

Real-World Economic Value of a 21-Gene Assay in Early-Stage Breast Cancer

Universal gene expression profiling of patients with stage II breast cancer resulted in outpatient savings of $11,000 (inclusive of testing costs) within 6 months of initiation of medical therapy.



Anita L. Hart, MD

Latest:

Excess Hospitalization Days in an Academic Medical Center: Perceptions of Hospitalists and Discharge Planners

We assessed the frequency of and reasons for medically unnecessary hospital days, which affect patients, payers, hospitals, and healthcare providers.




Mark W. Friedberg, MD, MPP

Latest:

Option Pricing: A Flexible Tool to Disseminate Shared Savings Contracts

By pricing options that protect providers from downside risk,health plans can more clearly evaluate different shared savings contracts and expand them to smaller providers.


© 2024 MJH Life Sciences
AJMC®
All rights reserved.